599 related articles for article (PubMed ID: 20373898)
1. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
[TBL] [Abstract][Full Text] [Related]
2. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
Nadal J; Carreras E; Canut MI
Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
[TBL] [Abstract][Full Text] [Related]
3. Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings.
Hershberger VS; Augsburger JJ; Hutchins RK; Raymond LA; Krug S
Ophthalmology; 2004 Jun; 111(6):1215-21. PubMed ID: 15177974
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
[TBL] [Abstract][Full Text] [Related]
6. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
Lee DY; Jeong HS; Sohn HJ; Nam DH
Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
[TBL] [Abstract][Full Text] [Related]
7. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
Khuthaila MK; Hsu J; Chiang A; DeCroos FC; Milder EA; Setlur V; Garg SJ; Spirn MJ
Am J Ophthalmol; 2013 Apr; 155(4):757-63, 763.e1-2. PubMed ID: 23317651
[TBL] [Abstract][Full Text] [Related]
8. Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study.
Yeh PT; Yang CM; Yang CH; Huang JS
Ophthalmology; 2005 Dec; 112(12):2095-102. PubMed ID: 16225926
[TBL] [Abstract][Full Text] [Related]
9. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
Neely KA; Scroggs MW; McCuen BW
Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
11. Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy.
Foster RE; Lowder CY; Meisler DM; Zakov ZN; Meyers SM; Ambler JS
Ophthalmic Surg; 1993 Jul; 24(7):446-52. PubMed ID: 8351090
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH; Chen MS
Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of 25-gauge pars plana vitrectomy in the surgical management of proliferative diabetic retinopathy.
Schoenberger SD; Miller DM; Riemann CD; Foster RE; Sisk RA; Hutchins RK; Petersen MR
Ophthalmic Surg Lasers Imaging; 2011; 42(6):474-80. PubMed ID: 21902167
[TBL] [Abstract][Full Text] [Related]
14. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
[TBL] [Abstract][Full Text] [Related]
16. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.
Kim DY; Kim JG; Kim YJ; Joe SG; Lee JY
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7040-6. PubMed ID: 25298415
[TBL] [Abstract][Full Text] [Related]
17. [Epiretinal membrane formation after pars plana vitrectomy in proliferative diabetic retinopathy].
Messmer E; Bornfeld N; Oehlschläger U; Heinrich T; Foerster MH; Wessing A
Klin Monbl Augenheilkd; 1992 Apr; 200(4):267-72. PubMed ID: 1614088
[TBL] [Abstract][Full Text] [Related]
18. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.
Jahn CE; Töpfner von Schutz K; Richter J; Boller J; Kron M
Ophthalmologica; 2004; 218(6):378-84. PubMed ID: 15564755
[TBL] [Abstract][Full Text] [Related]
19. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
20. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Lee BJ; Yu HG
Retina; 2010; 30(10):1671-7. PubMed ID: 21060273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]